Editorial: The development of biomarkers in psychiatry

Takashi Nakano; Masahiro Takamura; Takahiro A Kato; Shin-Ichi Kano

doi:10.3389/fpsyt.2022.1075993

Editorial: The development of biomarkers in psychiatry

Front Psychiatry. 2022 Dec 1:13:1075993. doi: 10.3389/fpsyt.2022.1075993. eCollection 2022.

Authors

Takashi Nakano^{1

2}, Masahiro Takamura³, Takahiro A Kato⁴, Shin-Ichi Kano⁵

Affiliations

¹ Department of Computational Biology, School of Medicine, Fujita Health University, Toyoake, Japan.
² Division of Computational Science, International Center for Brain Science, Fujita Health University, Toyoake, Japan.
³ Department of Neurology, Faculty of Medicine, Shimane University, Izumo, Japan.
⁴ Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
⁵ Department of Psychiatry and Behavioral Neurobiology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.

No abstract available

Keywords: attention-deficit hyperactivity disorder (ADHD); biomarkers; major depressive disorder; post-traumatic stress disorder (PTSD); psychiatry.

Publication types

Editorial